• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Studies of the Interaction of Influenza Virus RNA Polymerase PAN with Endonuclease Inhibitors

tetano

Editor, Senior Moderator
Interdiscip Sci. 2017 Jun 19. doi: 10.1007/s12539-017-0239-2. [Epub ahead of print]
[h=1]Studies of the Interaction of Influenza Virus RNA Polymerase PAN with Endonuclease Inhibitors.[/h] Dong LH[SUP]1[/SUP], Cao XR[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza virus is a major causative agent of respiratory viral infections, and RNA polymerase catalyzes its replication and transcription activities in infected cell nuclei. Since it is highly conserved in all virus strains, RNA polymerase becomes a key target of anti-influenza virus agents. Although experimental studies have revealed the good inhibitory activity of endonuclease inhibitors to RNA polymerase, the mechanism is still unclear. In this study, the docking and molecular dynamics simulations have been performed to explore the interaction of three kinds of endonuclease inhibitors with the subunit (PA[SUB]N[/SUB]) of RNA polymerase. Our calculations indicate that all these endonuclease inhibitors can bind to the binding pocket of PA[SUB]N[/SUB], in which the electronegative oxygen atoms of the inhibitors form a chelated structure with the two Mn[SUP]2+[/SUP] cations of the active center. The most important interaction between these inhibitors and PA[SUB]N[/SUB] is electrostatic interaction. The electron density of the chelate oxygen atoms determines the magnitude of the electrostatic energy, and the chelated structure and orientation of inhibitors depend largely on the distance between the chelate oxygen atoms.


[h=4]KEYWORDS:[/h] Docking; Influenza virus RNA polymerase; Inhibitor; Molecular dynamics simulation

PMID: 28631174 DOI: 10.1007/s12539-017-0239-2
 
Back
Top Bottom